- abrocitinibPhase 3 Readout Catalyst (PFE)
- acasunlimabPhase 3 Readout Catalyst (GMAB)
- alectinibPhase 2;Phase 3 Readout Catalyst (NUVL)
- anifrolumabPhase 3 Readout Catalyst (AZN)
- axitinibPhase 3 Readout Catalyst (PFE)
- belzutifanPhase 3 Readout Catalyst (MRK)
- binimetinibPhase 3 Readout Catalyst (PFE)
- cagrilintidePhase 3 Readout Catalyst (NVO)
- camizestrantPhase 3 Readout Catalyst (AZN)
- cenerimodPhase 3 Readout Catalyst (VTRS)
- cretostimogene grenadenorepvecPhase 3 Readout Catalyst (CGON)
- dapagliflozinPhase 3 Readout Catalyst (AZN)
- darolutamidePhase 3 Readout Catalyst (AZN)
- darovasertibPhase 2;Phase 3 Readout Catalyst (IDYA)
- datopotamab deruxtecanPhase 3 Readout Catalyst (AZN)
- daunorubicinPhase 2;Phase 3 Readout Catalyst (KURA)
- deucravacitinibPhase 3 Readout Catalyst (BMY)
- deucrictibantPhase 3 Readout Catalyst (PHVS)
- deuruxolitinibPhase 2;Phase 3 Readout Catalyst (TEVA)
- disitamab vedotinPhase 3 Readout Catalyst (PFE)
- donidalorsenPhase 3 Readout Catalyst (IONS)
- efgartigimodPhase 2;Phase 3 Readout Catalyst (ARGX)
- eftilagimod alfaPhase 3 Readout Catalyst (IMMP)
- eftilagimod alphaPhase 2;Phase 3 Readout Catalyst (IMMP)
- elranatamabPhase 3 Readout Catalyst (PFE)
- encorafenibPhase 3 Readout Catalyst (PFE)
- enlicitide decanoatePhase 3 Readout Catalyst (MRK)
- epcoritamabPhase 3 Readout Catalyst (GMAB)
- erwinia asparaginasePhase 2;Phase 3 Readout Catalyst (DAN)
- fianlimabPhase 3 Readout Catalyst (REGN)
- golcadomidePhase 3 Readout Catalyst (BMY)
- ianalumabPhase 3 Readout Catalyst (NVS)
- ibrutinibPhase 3 Readout Catalyst (MRK)
- ifinatamab deruxtecanPhase 3 Readout Catalyst (MRK)
- inclisiranPhase 3 Readout Catalyst (NVS)
- iptacopanPhase 3 Readout Catalyst (NVS)
- ivonescimabPhase 3 Readout Catalyst (SMMT)
- laroprovstatPhase 3 Readout Catalyst (AZN)
- lebrikizumabPhase 3 Readout Catalyst (LLY)
- lerotinibPhase 3 Readout Catalyst (SBFM)
- lisaftoclaxPhase 3 Readout Catalyst (AAPG)
- litifilimabPhase 3 Readout Catalyst (BIIB)
- lorlatanibPhase 3 Readout Catalyst (PFE)
- lutikizumabPhase 3 Readout Catalyst (ABBV)
- maridebart cafraglutidePhase 3 Readout Catalyst (AMGN)
- mercaptopurinePhase 2;Phase 3 Readout Catalyst (DAN)
- mevrometostatPhase 3 Readout Catalyst (PFE)
- mezigdomidePhase 3 Readout Catalyst (BMY)
- mibavademabPhase 3 Readout Catalyst (REGN)
- midazolamPhase 3 Readout Catalyst (COGT)
- migalastatPhase 3 Readout Catalyst (SNY)
- minoxidilPhase 3 Readout Catalyst (SBFM)
- monalizumabPhase 3 Readout Catalyst (AZN)
- nelarabinePhase 2;Phase 3 Readout Catalyst (DAN)
- nemtabrutinibPhase 3 Readout Catalyst (MRK)
- niraparibPhase 2;Phase 3 Readout Catalyst (IMNN)
- obicetrapibPhase 3 Readout Catalyst (NAMS)
- oleclumabPhase 3 Readout Catalyst (AZN)
- olezarsenPhase 3 Readout Catalyst (IONS)
- olverembatinibPhase 3 Readout Catalyst (AAPG)
- olvimulogene nanivacirepvecPhase 3 Readout Catalyst (GNLX)
- orforglipronPhase 3 Readout Catalyst (LLY)
- paltusotinePhase 3 Readout Catalyst (CRNX)
- patidegibPhase 3 Readout Catalyst (SLGL)
- pazopanibPhase 3 Readout Catalyst (INTS)
- pegaspargasePhase 2;Phase 3 Readout Catalyst (DAN)
- pelabresibPhase 3 Readout Catalyst (NVS)
- pitolisantPhase 3 Readout Catalyst (HRMY)
- povorcitinibPhase 3 Readout Catalyst (INCY)
- ralinepagPhase 3 Readout Catalyst (UTHR)
- ravulizumabPhase 3 Readout Catalyst (AZN)
- recombinant human tissue kallikreinPhase 2;Phase 3 Readout Catalyst (DMAC)
- rescue medicationsPhase 3 Readout Catalyst (MRK)
- resmetiromPhase 3 Readout Catalyst (MDGL)
- retatrutidePhase 3 Readout Catalyst (LLY)
- rezvilutamidePhase 3 Readout Catalyst (AZN)
- rilvegostomigPhase 3 Readout Catalyst (AZN)
- rinaPhase 3 Readout Catalyst (GMAB)
- ritlecitinibPhase 3 Readout Catalyst (PFE)
- ritlecitinib higherPhase 3 Readout Catalyst (PFE)
- ritlecitinib lowerPhase 3 Readout Catalyst (PFE)
- rosuvastatin calciumPhase 3 Readout Catalyst (MRK)
- sacituzumab govitecan hziyPhase 3 Readout Catalyst (GILD)
- setmelanotidePhase 3 Readout Catalyst (RYTM)
- sonelokimabPhase 3 Readout Catalyst (MLTX)
- sotagliflozinPhase 3 Readout Catalyst (LXRX)
- sotorasibPhase 3 Readout Catalyst (AMGN)
- supportive care measuresPhase 3 Readout Catalyst (MRK)
- tafasitamabPhase 3 Readout Catalyst (INCY)
- talazoparibPhase 3 Readout Catalyst (PFE)
- tapinarofPhase 3 Readout Catalyst (OGN)
- tarlatamabPhase 3 Readout Catalyst (AMGN)
- telisotuzumab adizutecanPhase 3 Readout Catalyst (ABBV)
- telitaciceptPhase 3 Readout Catalyst (VOR)
- tezepelumabPhase 3 Readout Catalyst (AZN)
- tirzepatidePhase 3 Readout Catalyst (LLY)
- tisagenlecleucelPhase 3 Readout Catalyst (NVS)
- tocilizumabPhase 3 Readout Catalyst (MRK)
- tofacitinibPhase 3 Readout Catalyst (PFE)
- tradipitantPhase 3 Readout Catalyst (VNDA)
- tulisokibartPhase 3 Readout Catalyst (MRK)
- utomilumabPhase 3 Readout Catalyst (PFE)
- vepdegestrantPhase 3 Readout Catalyst (PFE)
- zanidatamabPhase 3 Readout Catalyst (JAZZ)
- zanubrutinibPhase 3 Readout Catalyst (ONC)
- zasocitinibPhase 3 Readout Catalyst (TAK)
- ziltivekimabPhase 3 Readout Catalyst (NVO)
- zodasiranPhase 3 Readout Catalyst (ARWR)
Informational data derived from public trial registries. Not investment advice.